Outsourcing now extends beyond IT and BPO and this company operates in this transformed ecosystem.
Prime Stock recommendation: A unique digital play in the life sciences space Read More »
Our pick in the capital intensive hospital sector.
Prime Stock Recommendation: A niche hospital stock with bright prospects Read More »
Results update for 9 of our Prime Stocks.
Prime Stocks: Results update 3 for quarter ending September 2024 Read More »
Results update for 8 of our Prime Stocks.
Prime Stocks: Results update 2 for quarter ending September 2024 Read More »
The Nifty IT index may still be at January 2022 levels but what’s in store for the sector? Find out in the report!
IT Sector update: Decoding the Q2 FY25 Results and Outlook Read More »
A key player in an entertainment avenue that hasn’t gone out of fashion!
Prime Stock Recommendation: The star in the hard-to-crack entertainment business Read More »
Results update for 8 of our Prime Stocks.
Prime Stocks: Results update 1 for quarter ending September 2024 Read More »
This stock has run up significantly since our BUY call. Find out why we are moving it to a HOLD and what that means.
Prime Stocks Update: Moving this healthcare stock from a BUY to a HOLD Read More »
A stock pick that is well-positioned to capitalise on the anticipated recovery in discretionary spending in the US.
Prime Stock recommendation: An IT major to play the tech revival Read More »
Looking at the consumer electricals space through the lens of the Q1 FY 25 results.
Consumer Electricals: Heatwave lights things up for this space Read More »
Find out why we are moving this Prime Stock to a SELL.
Prime Stocks Alert: Moving this automotive player to a Sell Read More »
Find out why it’s time to lock into your gains on this pharma stock.
Prime Stock update: Book Profits on this pharma player Read More »
The purpose of these disclosures is to provide essential information about the Research Services in a manner to assist and enable the prospective client/client in making an informed decision for engaging in Research services before onboarding. History, Present business and Background: PrimeInvestor Financial Research Private Limited is registered with SEBI as Research Analyst with registration no. INH200008653. The Research Analyst got its registration on August 19, 2021 and is engaged in offering research and recommendation services. Terms and conditions of Research Services: The Research Services will be limited to providing independent research recommendation and shall not be involved in any advisory or portfolio allocation services. The Research Analyst never guarantees the returns on the recommendation provided. Investor shall take note that Investment/trading in stocks/Index or other securities is always subject to market risk. Past performance is never a guarantee of same future results. The Research Analyst shall not be responsible for any loss to the Investors. Disciplinary history: There are no pending material litigations or legal proceedings against the Research Analyst. As on date, no penalties / directions have been issued by SEBI under the SEBI Act or Regulations made there under against the Research Analyst relating to Research Analyst services. Details of its associates: No associates. Disclosures with respect to Research and Recommendations Services: The Research Analyst or its directors or any of its officer/employee does not trade in securities which are subject matter of recommendation. There are no actual or potential conflicts of interest arising from any connection to or association with any issuer of products/ securities, including any material information or facts that might compromise its objectivity or independence in the carrying on of Research Analyst services. Such conflict of interest shall be disclosed to the client as and when they arise. Research Analyst or its directors or its employee or its associates have not received any compensation from the company which is subject matter of recommendation. Research Analyst or its directors or its employee or its associates have not managed or co-managed the public offering of any company. Research Analyst or its directors or its employee or its associates have not received any compensation for investment banking or merchant banking of brokerage services from the subject company. Research Analyst or its directors or its employee or its associates have not received any compensation for products or services other than above from the subject company. Research Analyst or its directors or its employee or its associates have not received any compensation or other benefits from the Subject Company or 3rd party in connection with the research report/ recommendation. The subject company was not a client of Research Analyst or its directors or its employee or its associates during twelve months preceding the date of recommendation services provided. Research Analysts or its directors or its employee or its associates has not served as an officer, director or employee of the subject company. Research Analysts has not been engaged in market making activity of the subject company.
Full disclosures and disclaimers
Compliance Officer Details: Name: Srikanth Meenakshi; Email: contact@primeinvestor.
Grievance Officer Details: Name: Srikanth Meenakshi; Email: contact@primeinvestor.
